New technologies from diffusion-weighted imaging to ultrasonography are being studied and refined, but much is yet to be understood
Search results for: gout
President’s Perspective: The ACR and ARHP Advance Rheumatology Through International Collaboration
By forging new connections and strengthening efforts with global organizations such as EULAR, the College hopes to enhance the science, clinical care, and perceived value of rheumatology
Speak Out Rheum: Fifty Years of APLAR
A past president reminisces about the formation and history of the Asia Pacific League of Associations for Rheumatology on its 50th anniversary
The Pharmacist’s Role in Managing Rheumatic Diseases
An overview of the many benefits pharmacists can bring to a multidisciplinary healthcare team
Quality Patient Care in Rheumatology a Challenge to Define, Measure
Rapid change and increasing costs in healthcare have sparked renewed interest in providing high-quality care, but demonstrating quality is difficult
Speak Out Rheum: The First Days of Rheumatology
How the field has grown and flourished since rheumatology became a word in 1949
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Rheuminations: Circadian Rhythms May Play Role in Inflammatory Disease
Research into how the timing of light and dark exposures control our lives could provide clues to why some people have immunologic disorders
Letter: Should We Monitor Asymptomatic Hyperuricemia?
Why have physicians stopped routine screening for hyperuricemia and is there any value to this screening?
Letter: There’s No Reason Now to Screen for Uric Acid
Screening was common in the 1970s and before, but new studies demonstrate that most hyperuricemia patients never developed gout or kidney stones, so enthusiasm for screening waned
- « Previous Page
- 1
- …
- 43
- 44
- 45
- 46
- 47
- …
- 57
- Next Page »